Avalyn Pharma Inc. (NASDAQ:AVLN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Heather Turner Other companies: LB Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 10, 2025); Terns Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2024); Lyell Immunopharma, Inc. (Chief General Counsel · Jun 16, 2021 – Mar 16, 2022 · Past); Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 12, 2018 – Feb 25, 2019 · Past); Atara Biotherapeutics, Inc. (Former EVP, GC & Sec. · Feb 6, 2018 – Feb 9, 2018 · Past) | Director · Since at least Apr 29, 2026 |
| Erin Lavelle Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past); Climb Bio, Inc. (COO & CFO · Aug 9, 2021 – Oct 31, 2022 · Past); Alder BioPharmaceuticals Inc (Chief Operating Officer · Apr 16, 2018 – Oct 22, 2019 · Past) | Director · Since at least Apr 29, 2026 |
| Douglas R Carlson Other companies: ImageneBio, Inc. (COO & EVP of Finance · Mar 25, 2021 – Mar 25, 2021 · Past); Collegium Pharmaceutical, Inc. (VP Corp. Devlp · May 6, 2015 – May 6, 2015 · Past) | See Remarks · Since at least Apr 29, 2026 |
| Jill Carroll Other companies: Arcellx Inc (Director · Since at least Feb 3, 2022); Pandion Therapeutics Inc (Director · Apr 1, 2021 – Apr 1, 2021 · Past) | Director · Since at least Apr 29, 2026 |
| Jon Congleton Other companies: Immunic, Inc. (Director · Since at least Mar 27, 2026); Mineralys Therapeutics, Inc. (Chief Executive Officer, Director · Since at least Feb 9, 2023) | Director · Since at least Apr 29, 2026 |
| Jon Congleton Other companies: Mineralys Therapeutics, Inc. (Chief Executive Officer · Since at least Oct 2, 2026); Immunic, Inc. (Independent Director · Since at least May 13, 2026) | Since at least Apr 6, 2026 |
| Lyn Baranowski Other companies: Rani Therapeutics Holdings, Inc. (Director · Nov 10, 2021 – May 25, 2022 · Past) | Chief Executive Officer · Since at least Apr 29, 2026 |
| Robert J. Meyer Other companies: Chimerix Inc (Director · Jun 20, 2024 – Apr 21, 2025 · Past) | Director · Since at least Sep 15, 2026 |
| Adam Golden | General Counsel and Head of Business Development · Since at least Jun 3, 2026 |
| Craig Conoscenti | Senior Vice President, Clinical Development · Since at least May 21, 2026 |
| David Friedman | MANAGING DIRECTOR AND SENIOR ANALYST, Suvretta Capital Management · Since at least Nov 5, 2026 |
| Doug Carlson | Chief Financial Officer and Chief Business Officer · Since at least Nov 4, 2026 |
| Frank Salisbury | Senior Vice President, Commercial · Since at least Jun 3, 2026 |
| Howard M. Lazarus | Chief Medical Officer · Since at least Apr 29, 2026 |
| Jill Denning | Senior Vice President, Clinical Development Operations · Since at least Nov 4, 2026 |
| Jim Bishop | Senior Vice President, Business Operations · Since at least Nov 4, 2026 |
| Kate Haviland | Since at least Nov 4, 2026 |
| Kelly Donoghue | Sr. Manager, IR and Corporate Communications · Since at least Nov 3, 2026 |
| Kimberley Cummings | SENIOR VICE PRESIDENT, REGULATORY AFFAIRS · Since at least Nov 5, 2026 |
| Melissa Rhodes | Chief Operating Officer · Since at least Apr 29, 2026 |
| Stephen Pham | Senior Vice President, Product Development · Since at least Nov 5, 2026 |